site stats

Hipporad

WebbBACKGROUND: The current study was aimed at investigating the feasibility of hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost (HA-WBRT+SIB) for metastases and at assessing tumor control in comparison with conventional whole-brain radiation therapy (WBRT) in patients with multiple brain … WebbHA-WBRT patients were treated analogously to the ongoing HIPPORAD-trial (DRKS00004598) protocol with 30 Gy in 12 fractions and dose to 98% of the …

Hippocampus‐avoidance whole‐brain radiation therapy with a …

WebbHIPPORAD. CNS diseases or syndromes accompanied by cognitive deficits or radiological changes of the brain, e.g., dementia, depression, clinically manifest hypertensive encephalopathy, meningiosis carcinomatosa-- Previous brain irradiation or surgical resection of brain tumours (biopsy allowed) Webb16 jan. 2015 · Purpose Hippocampal-avoidance whole brain radiotherapy (HA-WBRT) for multiple brain metastases may prevent treatment-related cognitive decline, compared to standard WBRT. Additionally, simultaneous integrated boost (SIB) on individual metastases may further improve the outcome. Here, we present initial data concerning … on the same token phrase https://wearepak.com

Hippocampus‐avoidance whole‐brain radiation therapy with a …

WebbForschungsverbünde; Mechanismen der Resistenzentwicklung und Optimierung antiviraler Strategien bei Hepatitis C Virusinfektion unter Einbeziehung integrativer Modelle der … Webbimaging (HIPPORAD) a phase II prospective randomized multicenter trial (NOA-14, ARO 2015 3, DKTK-ROG) WebbPubMed journal article: Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG). Download Prime PubMed App to iPhone, iPad, or Android on the same track meaning

Optimale Therapie bei multiplen HirnmetastasenOptimal …

Category:STUDY PROTOCOL Open Access Whole-brain irradiation with

Tags:Hipporad

Hipporad

PRIME PubMed Whole-brain irradiation with hippocampal …

Webb1 sep. 2024 · HA-WBRT patients were treated analogously to the ongoing HIPPORAD-trial (DRKS00004598) protocol with 30 Gy in 12 fractions and dose to 98% of the …

Hipporad

Did you know?

Webb6 mars 2024 · Background. The current study was aimed at investigating the feasibility of hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost (HA-WBRT+SIB) for metastases and at assessing tumor control in comparison with conventional whole-brain radiation therapy (WBRT) in patients with multiple brain … WebbHIPPORAD-Trial (Hippocamps-sparing WBRT with dose escalation on multiple brain metastases) 11/2013 – 12/2024 Medical trial coordinator GLIAA-Trial (Amino acid-PET vs. MRT-based reirradiation in recurrent glioblastoma) ICH-GCP with date 02/2014 University of Freiburg 12.10.2024 Kliniken Maria-Hilf GmbH, Mönchengladbach

WebbHIPPORAD-Study (NOA-14 / ARO 2015-3) Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (4 -10 brain metastases) Treatment arm A: Experimental intervention: HA-WBRT with concomitant boost to the metastases, total dose to whole brain (PTV= Webb22 okt. 2024 · Popp et al 9 reported similar results in a recently published single-institution feasibility trial of HA-WBRT + SIB: HA-WBRT 30 Gy in 12 fractions, SIB 51 Gy/42 Gy in 12 fractions for macrometastases/surgical cavities. The neurocognitive function component of this approach is being evaluated further in HIPPORAD, 10 a randomized phase II trial …

Webb7 juni 2024 · This is a protocol of a randomized phase II trial designed to test a new strategy of WBRT for preventing cognitive decline and increasing tumor control in patients with multiple brain metastases. The HIPPORAD trial is registered with the German Clinical Trials Registry ( DRKS00004598 , registered 2 June 2016). WebbNational Center for Biotechnology Information

WebbDiscussion This is a protocol of a randomized phase II trial designed to test a new strategy of WBRT for preventing cognitive decline and increasing tumor control in patients with …

Webbimaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-14, ARO 2015–3, DKTK-ROG) Anca-Ligia Grosu1,2, Lars Frings1,3, Iryna Bentsalo4, Oliver Oehlke1,5, Franziska Brenner1,6, Angelika Bilger1, Jamina Tara Fennell1, Thomas Rothe1, Sabine Schneider-Fuchs7, Erika Graf8, Claudia Schmoor7, Jürgen Beck9, on the same wavelength memeWebb19 aug. 2024 · HA-WBRT patients were treated analogously to the ongoing HIPPORAD-trial (DRKS00004598) protocol with 30 Gy in 12 fractions and dose to 98% of the … on the same understandingWebb27 nov. 2024 · Brain metastases (BMs) are intracranial neoplasms that occur in 10%–20% of adult patients with cancer. 1 Over the years, the frequency of BMs has increased due to the increase in overall survival of cancer patients due to improvements in systemic therapies. 2 Improvements in diagnostic imaging approaches have also led to a further … on the same wavelength idiomWebb22 dec. 2015 · Overall, sparing of the hippocampi seems to be beneficial for patients undergoing WBRT. In Germany a prospective randomized multicenter phase II study is being launched (the HIPPORAD study) to investigate the neurocognitive outcome of patients with metastases receiving WBRT with hippocampal sparing and dose escalation . on the same wavelength gifWebbDiscussion This is a protocol of a randomized phase II trial designed to test a new strategy of WBRT for preventing cognitive decline and increasing tumor control in patients with multiple brain metastases. Trial registration The HIPPORAD trial is registered with the German Clinical Trials Registry ( DRKS00004598 , registered 2 June 2016). on the same vaneWebbWhole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective … ios 16 how to get notifications at the topWebbHA-WBRT patients were treated analogously to the ongoing HIPPORAD-trial (DRKS00004598) protocol with 30 Gy in 12 fractions and dose to 98% of the … on the same wavelength synonym